Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
06/2005
06/16/2005US20050131035 Medicaments
06/16/2005US20050131024 Antiinflammatory agents; autoimmune diseases; anticancer agents
06/16/2005US20050131023 Use of pleuromutilins for the treatment of disorders caused by helicobacter pylori
06/16/2005US20050131011 Antiinflammatory agents; viricides against human t-cell/lymphoma virus or retroviruses
06/16/2005US20050131009 Urea substituted imidazoquinolines
06/16/2005US20050131005 4-azasteroid derivatives as androgen receptor modulators
06/16/2005US20050130998 Central nervous ystem diorders; Alzheimer's disease ; anticancer agents
06/16/2005US20050130997 Pyrimidinone viral polymerase inhibitors
06/16/2005US20050130993 Synthesis and purification of valacyclovir
06/16/2005US20050130981 Compounds
06/16/2005US20050130965 Inhibitors of p38 kinase
06/16/2005US20050130964 e.g 8-oxa-1-thia-benzo[e]naphtho[3,2-h]azulene-2-carboxylic acid ethyl ester; rheumatoid arthritis
06/16/2005US20050130952 Photodynamic therapy in selective cell inactivation in blood and treating immune dysfunction diseases
06/16/2005US20050130940 Fungal infections; water soluble phosphate derivatives of triazole drugs such as fluconazole
06/16/2005US20050130935 Combination of a beta-2-adrenoceptor agonists and an aminosugars and their use for the treatment immunomodulatory disorders
06/16/2005US20050130927 For treating neoplasm, hypoproliferation, hyperproliferation, degenerative and neurodegenerative diseases, ischaemia, immune system disorder, infectious disease, or metabolic dysfunction
06/16/2005US20050130914 Methods of administering dalbavancin for treatment of skin and soft tissue infections
06/16/2005US20050130909 Gram-positive bacterial infection of skin and soft tissue; soluble
06/16/2005US20050130903 Therapeutic agents and methods of use thereof for the modulation of angiogenesis
06/16/2005US20050130889 Analog further comprises an amino acid substitution wherein the cysteine residue at BPI amino acid position 132 is replaced by another amino acid; for treating gram-negative bacterial infections in a subject; bactericidal for gram-positive bacteria and mycoplasma; enhances effectiveness of antibiotics
06/16/2005US20050130884 Pharmacologically active antiviral peptides and methods of their use
06/16/2005US20050130881 Single amino acid based compounds for counteracting effects of reactive oxygen species and free radicals
06/16/2005US20050130304 Regulation of endogenous gene expression in cells using zinc finger proteins
06/16/2005US20050130242 Uses of aldose-1-epimerase (mutarotase) for diagnosis and therapy of inflammatory diseases and sepsis
06/16/2005US20050130145 polynucleotides which identify and encode human secreted proteins (SECP); expression vectors, host cells, antibodies, and agonists; drug screening
06/16/2005US20050130135 Hepatitis a virus nucleotide sequences, recombinant proteins and uses thereof
06/16/2005US20050130128 Methods for detecting NEBR1 expression in a biological sample by contacting a sample with the labeled antibody; inhibits HIV replication in host cells
06/16/2005US20050130127 Coronavirus-like particles comprising functionally deleted genomes
06/16/2005US20050130125 End of aids for general virology, based on profound science as protein foldings: safe vaccines, universal antimicrobial means, mad cow end
06/16/2005US20050129784 Use of a chemically stabilized chlorite solution for inhibiting an antigen-specific immune response
06/16/2005US20050129754 Halogenated anesthetic in emulsion with lecithin
06/16/2005US20050129739 Production and use of a polar lipid-rich fraction containing omega-3 and/or omega-6 highly unsaturated fatty acids from microbes, genetically modified plant seeds and marine organisms
06/16/2005US20050129736 Compositions and methods for treating or preventing diseases of body passageways
06/16/2005US20050129714 Vaccine against salmonid rickettsial septicaemia based on arthrobacter cells
06/16/2005US20050129701 Antibody to latent membrane proteins and uses thereof
06/16/2005US20050129694 At least one (SEK) kinase inhibitor that acts in an synergistic manner to those inhibiting the virus multiplication for the Raf/MEK/ERK signal transmission path; influenza viricides
06/16/2005US20050129667 treating leukemia or bone cancer by injecting a samarium comples of ethylenediaminetetramethanephosphonic acid and another chemotherapeutic agent; stem cell/bone marrow transplantation and/or restoration; patient is not subjected to total body irradiation
06/16/2005US20050129657 Interferon-alpha induced gene
06/16/2005US20050129623 Inhalable aztreonam aerosol for treatment and prevention of pulmonary bacterial infections
06/16/2005US20050129611 Drugs for the diagnosis of tissue reproductive activity or the treatment of proliferative diseases
06/16/2005DE10350929A1 Use of dispirotripiperazine derivatives to treat fungal infections or to prevent adhesion of fungi to surfaces
06/16/2005CA2582559A1 Treatment of hpv infections and cancer
06/16/2005CA2547670A1 Treating infectious diseases using ice inhibitors
06/16/2005CA2547229A1 Glycosylated triketide delta lactones
06/16/2005CA2547008A1 New class of gamma delta t cells activators and use thereof
06/16/2005CA2546926A1 Compositions for the treatment of afflictions of the oral cavity and upper respiratory tract
06/16/2005CA2546247A1 Ppar agonists for the treatment of hcv infection
06/16/2005CA2545425A1 Azole-based kinase inhibitors
06/16/2005CA2545271A1 Association of antimicrobial compounds with surfaces and polymers
06/16/2005CA2543090A1 Nucleoside compounds for treating viral infections
06/15/2005EP1541690A2 Transfer of mRNA using polycationic compounds
06/15/2005EP1541673A1 Novel probiotics for pet food applications
06/15/2005EP1541672A1 Composition for promoting the proliferation of lactobacillus casei subsp. casei
06/15/2005EP1541584A1 A group of novel synthetic antibiotic peptides
06/15/2005EP1541574A1 Triazaspiro 5.5 undecane derivatives and drugs comprisi ng the same as the active ingredient
06/15/2005EP1541573A1 Novel crystals of triazaspiro 5.5 undecane derivative
06/15/2005EP1541572A1 Thioether substituted imidazoquinolines
06/15/2005EP1541571A1 Bicyclic unsaturated tertiary amine compound
06/15/2005EP1541563A1 Ccr4 antagonist and medicinal use thereof
06/15/2005EP1541558A1 Heterocyclic compound having hiv integrase inhibitory activity
06/15/2005EP1541170A1 Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide
06/15/2005EP1541162A1 Intravaginal washing agent
06/15/2005EP1541153A1 Hepatitis c virus inhibitor comprising alpha-glycosylceramide as the active ingredient
06/15/2005EP1541125A1 Spreadable compositions for topical use, a process of making same and uses thereof
06/15/2005EP1541036A1 Algae feeds for aquaculture and agriculture
06/15/2005EP1540559A2 Bioinformatic method for identifying surface-anchored proteins from gram-positive bacteria and proteins obtained thereby
06/15/2005EP1539977A2 Tiacumicin production
06/15/2005EP1539964A2 Collectin-complement activating protein chimeras
06/15/2005EP1539962A1 Polyene polyketides and methods of production
06/15/2005EP1539927A1 Probiotic bacterium: lactobacillus fermentum
06/15/2005EP1539811A2 Production of bispecific molecules using polyethylene glycol linkers
06/15/2005EP1539809A2 Hcv fusion proteins with modified ns3 domains
06/15/2005EP1539808A2 gM-NEGATIVE EHV-MUTANTS WITHOUT HETEROLOGOUS ELEMENTS
06/15/2005EP1539783A1 Inhibitors of nucleoside phosphorylases and nucleosidases
06/15/2005EP1539769A1 Bicyclic heteroaromatic compounds as kinase inhibitors
06/15/2005EP1539763A1 Azaindole kinase inhibitors
06/15/2005EP1539760A2 Azapurine derivatives
06/15/2005EP1539752A1 Preparation of 1h-imidazo 4,5-c quinolin-4-amines via novel 1h-imidazo 4,5-c quinolin-4-cyano and 1h-imida zo 4,5-c quinolin-4-carboxamide intermediates
06/15/2005EP1539745A1 N-aryl-2-oxazolidinones and their derivatives
06/15/2005EP1539744A2 N-hydroxyamide derivatives possessing antibacterial activity
06/15/2005EP1539741A1 2-thio-substituted imidazole derivatives and their use in pharmaceutics
06/15/2005EP1539734A1 Piperidine quinolyl propyl derivatives and use thereof as antimicrobial agents
06/15/2005EP1539730A1 Novel compunds, pharmaceutical compositions containing same, and methods of use for same
06/15/2005EP1539716A1 Benzodiazepine derivatives and pharmaceutical compositions containing them
06/15/2005EP1539714A2 8-hydroxy-1-oxo-tetrahydropyrrolopyrazine compounds useful as hiv integrase inhibitors
06/15/2005EP1539701A1 Caspase inhibitors and uses thereof
06/15/2005EP1539696A2 Process for preparing quinolin antibiotic intermediates
06/15/2005EP1539695A1 N-4-piperidinyl compounds as ccr5 modulators
06/15/2005EP1539692A1 Furanone derivatives and methods of making same
06/15/2005EP1539683A2 Phenol derivatives and their use as rotamase inhibitors
06/15/2005EP1539679A2 Oxime and/or hydrazone containing nitrosated and/or nitrosylated cyclooxigenase-2 selective inhibitors, compositions and methods of use
06/15/2005EP1539678A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc-chemokine receptor ligands
06/15/2005EP1539674A1 Amino-propanol derivatives
06/15/2005EP1539662A1 Cannabinoid receptor ligands
06/15/2005EP1539284A2 Liquid aerosol formulations and aerosol generating devices and methods for generating aerosols
06/15/2005EP1539245A2 Methods and materials for treating human papillomavirus infections
06/15/2005EP1539224A1 Antimicrobial composition and method for use
06/15/2005EP1539215A2 Adjuvant-free peptide vaccine
06/15/2005EP1539191A1 Glycoalkaloid compositions and various uses thereof
06/15/2005EP1539188A2 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
1 ... 962 963 964 965 966 967 968 969 970 971 972 973 974 975 976 977 978 979 980 981 982 ... 1798